Literature DB >> 33779998

Erenumab for migraine prevention in a patient with mitochondrial encephalopathy, lactate acidosis, and stroke-like episodes syndrome: A case report.

Steffen Naegel1, Philipp Burow1, Dagny Holle2, Dietrich Stoevesandt3, Simon Heintz1, Annemarie Thaele1, Stephan Zierz1, Torsten Kraya1,4.   

Abstract

Entities:  

Keywords:  calcitonin gene-related peptide; calcitonin gene-related peptide receptor antibody; erenumab; lactate acidosis; mitochondria; mitochondrial encephalopathy; stroke-like episodes

Mesh：

Substances：

Year:  2021        PMID： 33779998     DOI： 10.1111/head.14101

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  3 in total

1.  Preventive migraine treatment in mitochondrial diseases: a case report of erenumab efficacy and literature review.

Authors:  Guido Primiano; Eleonora Rollo; Marina Romozzi; Paolo Calabresi; Serenella Servidei; Catello Vollono
Journal:  Neurol Sci       Date:  2022-09-13       Impact factor: 3.830

Review 2.  Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review.

Authors:  Ann M Murray; Jennifer I Stern; Carrie E Robertson; Chia-Chun Chiang
Journal:  Curr Pain Headache Rep       Date:  2022-09-05

3.  Case report: Monoclonal CGRP-antibody treatment in a migraine patient with a mutation in the mitochondrial single-strand binding protein (SSBP1).

Authors:  Katharina Kaltseis; Elisabetta Indelicato; Gregor Broessner; Sylvia Boesch
Journal:  Front Neurol       Date:  2022-09-15       Impact factor: 4.086
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.